GSK Scrambles For N11.16bn To Payoff Stanbic Nominee, Other Shareholder Ahead Of…
Glaxo Smithkline Consumer Nigeria Plc which is finalising its exit from Nigerian is planning about N11.16bn…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithKline Proposes N17.4 Per Share Pay-Off Package For Shareholders
GlaxoSmithKline Consumer Nigeria Plc has proposed a N17.4 pay-off package for each share held by the company’s…
Expert Explains How Nigeria Can Benefit From GlaxoSmithKline’s Exit
Dr Timothy Zunkwe, a vaccinologist, says the exit of GlaxoSmithKline (GSK) from Nigeria could be a blessing in…
How Drop In Revenue, Low Profit Margin Forced GSK Group To Shut Down Factory In…
Contrary to speculation that GlaxoSmithKline Consumer Nigeria Plc shut down operations in Nigeria due to losses,…
JUST IN: GSK Group, Makers Of Panadol, Shuts Down Operations In Nigeria
GlaxoSmithKline Consumer Nigeria Plc said it has concluded arrangements to shut down its operations in Nigeria.
…
Covid-19 Boosts Pharmaceutical Companies Revenue By 8.3% To N24.73bn
The Covid-19 pandemic has boosted activities in the Nigerian pharmaceutical industry during the first half…